Reconstructing targetable pathways in lung cancer by integrating diverse omics data

Nature Communications

Volumn 4, Issue , 2013, Pages

  Balbin, O Alejandro ^a,b   Prensner, John R ^a,b   Sahu, Anirban ^a,b   Yocum, Anastasia ^a,b   Shankar, Sunita ^a,b   Malik, Rohit ^a,b   Fermin, Damian ^b   Dhanasekaran, Saravana M ^a,b   Chandler, Benjamin ^a   Thomas, Dafydd ^b   Beer, David G ^b   Cao, Xuhong ^a,b   Nesvizhskii, Alexey I ^a,b   Chinnaiyan, Arul M ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; K RAS PROTEIN; P21 ACTIVATED KINASE 1; PHOSPHOPROTEIN; PHOSPHOPROTEOME; PROTEIN KINASE LCK; PROTEOME; SCATTER FACTOR RECEPTOR; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ALGORITHM; DATA SET; DRUG; PROTEIN; PROTEOMICS; RECONSTRUCTION;

ALGORITHM; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER;

ALGORITHMS; ANTINEOPLASTIC AGENTS; BETA CATENIN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; LUNG NEOPLASMS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MOLECULAR TARGETED THERAPY; P21-ACTIVATED KINASES; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MET; RAS PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84886083037     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3617     Document Type: Article

References (67)

1. Karnoub, A. & Weinberg, R. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 9, 517-531 (2008). (Pubitemid 351881844)
2. Dogan, S. et al. Molecular epidemiology of EGFR and KRAS mutations in 3026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers. Clin. Cancer Res. 18, 6169-6177 (2012).
3. Riely, G. J. et al. Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clin. Cancer Res. 14, 5731-5734 (2008).
4. Society, A.C. American Cancer Society Figures and Facts (2012).
5. Barbie, D. et al. Systematic RNA interference reveals that oncogenic KRASdriven cancers require TBK1. Nature 462, 108-112 (2009).
6. Cox, A. D. & Der, C. J. Ras history: the saga continues. Small GTPases 1, 2-27 (2010).
7. Engelman, J. A. et al. Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat. Med. 14, 1351-1356 (2008).
8. Luo, J. et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137, 835-848 (2009).
9. Scholl, C. et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 137, 821-834 (2009).
10. Bild, A. et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439, 353-357 (2005). (Pubitemid 43128862)
11. Chang, J. et al. A genomic strategy to elucidate modules of oncogenic pathway signaling networks. Mol. Cell 34, 104-114 (2009).
12. Loboda, A. et al. A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors. BMC Med. Genomics 3, 26 (2010).
13. Singh, A. et al. A gene expression signature associated with K-Ras addiction reveals regulators of EMT and tumor cell survival. Cell 15, 489-500 (2009).
14. Singh, A. et al. TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers. Cell 148, 639-650 (2012).
15. Cheriyath, V. et al. Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas. PLoS One 6, e20199 (2011).
16. Bertotti, A. et al. Only a subset of Met-activated pathways are required to sustain oncogene addiction. Sci. Signal. 2, ra80 (2009).
17. Guo, A. et al. Signalling networks assembled by oncogenic EGFR and c-Met. Proc. Natl Acad. Sci. USA 105, 692-697 (2008). (Pubitemid 351171770)
18. Rikova, K. et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131, 1190-1203 (2007). (Pubitemid 350235027)
19. Carretero, J. et al. Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. Cancer Cell 17, 547-559 (2010).
20. Gatza, M. et al. A pathway-based classification of human breast cancer. Proc. Natl Acad. Sci. USA 107, 6994-6999 (2010).
21. Chari, R., Coe, B., Vucic, E., Lockwood, W. & Lam, W. An integrative multidimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer. BMC Syst. Biol. 4, 67 (2010).
22. Gry, M. et al. Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics 10, 365 (2009).
23. Shankavaram, U. T. et al. Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol. Cancer Ther. 6, 820-832 (2007). (Pubitemid 46554552)
24. Greenbaum, D., Colangelo, C., Williams, K. & Gerstein, M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 4, 117 (2003).
25. Fleiss, J. Review papers: the statistical basis of meta-analysis. Stat. Methods Med. Res. 2, 121-145 (1993).
26. Ramasamy, A., Mondry, A., Holmes, C. C. & Altman, D. G. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med. 5, e184 (2008).
27. Huang, S. s. C. & Fraenkel, E. Integrating proteomic, transcriptional, and interactome data reveals hidden components of signaling and regulatory networks. Sci. Signal. 2, ra40-ra40 (2009).
28. He, H. et al. P-21 activated kinase 1 knockdown inhibits beta-catenin signalling and blocks colorectal cancer growth. Cancer Lett. 317, 65-71 (2012).
29. Tarca, A. L. et al. A novel signaling pathway impact analysis. Bioinformatics 25, 75-82 (2009).
30. Jensen, L. et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 37, D412-D416 (2009).
31. Ljubic, I. et al. An algorithmic framework for the exact solution of the prizecollecting Steiner tree problem. Math. Program. 105, 427-449 (2006). (Pubitemid 41788328)
32. Dittrich, M., Klau, G., Rosenwald, A., Dandekar, T. & Muller, T. Identifying functional modules in protein-protein interaction networks: an integrated exact approach. Bioinformatics 24, i223-i231 (2008). (Pubitemid 351911677)
33. Bailly-Bechet, M. et al. Finding undetected protein associations in cell signaling by belief propagation. Proc. Natl Acad. Sci. USA 108, 882-887 (2011).
34. Ong, C. C. et al. Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells. Proc. Natl Acad. Sci. USA 108, 7177-7182 (2011).
35. Harr, M. W. et al. Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia. Cell Death Differ. 17, 1381-1391 (2010).
36. Shi, M. A. Constitutively active Lck kinase promotes cell proliferation and resistance to apoptosis through signal transducer and activator of transcription 5b activation. Mol. Cancer Res. 4, 39-45 (2006).
37. Giglione, C., Gonfloni, S. & Parmeggiani, A. Differential actions of p60c-Src and Lck kinases on the Ras regulators p120-GAP and GDP/GTP exchange factor CDC25Mm. Eur. J. Biochem. 268, 3275-3283 (2001). (Pubitemid 32823002)
38. Gherardi, E., Birchmeier, W., Birchmeier, C. & Vande Woude, G. Targeting MET in cancer: rationale and progress. Nat. Rev. Cancer 12, 89-103 (2012).
39. Chen, H. Y. et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N. Engl. J. Med. 356, 11-20 (2007).
40. Vogler, M. BCL2A1: the underdog in the BCL2 family. Cell Death Differ. 19, 67-74 (2011).
41. Datta, S. R. et al. Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev. Cell 3, 631-643 (2002). (Pubitemid 35339482)
42. Fang, X. et al. Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. Oncogene 18, 6635-6640 (1999).
43. Vizcaino, J. A. et al. The Proteomics Identifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 1, D1063-D1069 (2013).
44. Beausoleil, S., Villen, J., Gerber, S., Rush, J. & Gygi, S. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 24, 1285-1292 (2006). (Pubitemid 44564776)
45. Bodenmiller, B. & Aebersold, R. in Quantitative Analysis of Protein Phosphorylation on a System-Wide Scale by Mass Spectrometry-Based Proteomics, Vol. 470, 317-334 (Elsevier, 2010).
46. Choi, H., Fermin, D. & Nesvizhskii, A. Significance analysis of spectral count data in label-free shotgun proteomics. Mol. Cell Proteomics 7, 2373-2385 (2008).
47. Choudhary, C. & Mann, M. Decoding signalling networks by mass spectrometry-based proteomics. Nat. Rev. Mol. Cell Biol. 11, 427-439 (2010).
48. Domon, B. & Aebersold, R. Options and considerations when selecting a quantitative proteomics strategy. Nat. Biotechnol. 28, 710-721 (2010).
49. Griffin, N. et al. Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat. Biotechnol. 28, 83-89 (2010).
50. Keshamouni, V. et al. Temporal quantitative proteomics by iTRAQ 2D-LCMS/MS and corresponding mRNA expression analysis identify posttranscriptional modulation of actin-cytoskeleton regulators during TGF-Î2-induced epithelial-mesenchymal transition. J. Proteome Res. 8, 35-47 (2009).
51. Mueller, L., Brusniak, M.-Y., Mani, D. R. & Aebersold, R. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. J. Proteome Res. 7, 51-61 (2008). (Pubitemid 351171115)
52. Mueller, L. et al. SuperHirn-a novel tool for high resolution LC-MS-based peptide/protein profiling. Proteomics 7, 3470-3480 (2007). (Pubitemid 47597670)
53. Rush, J. et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23, 94-101 (2005). (Pubitemid 41724631)
54. Schreiber, T., Mäusbacher, N., Breitkopf, S., Grundner-Culemann, K. & Daub, H. Quantitative phosphoproteomics-an emerging key technology in signaltransduction research. Proteomics 8, 4416-4432 (2008).
55. Wong, J., Sullivan, M. & Cagney, G. Computational methods for the comparative quantification of proteins in label-free LCn-MS experiments. Brief. Bioinform. 9, 156-165 (2008). (Pubitemid 351517001)
56. Zhang, B. et al. Detecting differential and correlated protein expression in labelfree shotgun proteomics. J. Proteome Res. 5, 2909-2918 (2006). (Pubitemid 44749209)
57. Zhu, W., Smith, J. & Huang, C.-M. Mass spectrometry-based label-free quantitative proteomics. J. Biomed. Biotechnol. 2010, 1-7 (2010).
58. Xie, X. et al. A comparative phosphoproteomic analysis of a human tumor metastasis model using a label-free quantitative approach. Electrophoresis 31, 1842-1852 (2010).
59. Craig, R. & Beavis, R. C. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 20, 1466-1467 (2004). (Pubitemid 38931421)
60. Elias, J. E. & Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214 (2007). (Pubitemid 46358868)
61. The global proteome machine organization http://www.thegpm.org/crap/ index.html (2004).
62. Keller, A., Nesvizhskii, A., Kolker, E. & Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392 (2002). (Pubitemid 35215372)
63. Nesvizhskii, A., Keller, A., Kolker, E. & Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658 (2003). (Pubitemid 37082259)
64. Fermin, D., Basrur, V., Yocum, A. K. & Nesvizhskii, A. I. Abacus: a computational tool for extracting and pre-processing spectral count data for label-free quantitative proteomic analysis. Proteomics 11, 1340-1345 (2011).
65. Petrak, J. et al. Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 8, 1744-1749 (2008). (Pubitemid 351678270)
66. Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27-30, 2000). (Pubitemid 30047706)
67. Zhang, J. & Wiemann, S. KEGGgraph: a graph approach to KEGG pathway in R and bioconductor. Bioinformatics 25, 1470-1471 (2009).